BR100 Decreased By (-0.23%)
BR30 Decreased By (-0.61%)
KSE100 Decreased By (-0.41%)
KSE30 Decreased By (-0.67%)
BECO 5.81 Decreased By ▼ -0.22 (-3.65%)
BML 58.02 Increased By ▲ 5.27 (9.99%)
BOP 33.79 Decreased By ▼ -0.46 (-1.34%)
CNERGY 8.18 Increased By ▲ 0.02 (0.25%)
DCL 11.76 Decreased By ▼ -0.58 (-4.7%)
FCCL 53.34 Decreased By ▼ -0.55 (-1.02%)
FCSC 5.43 Increased By ▲ 0.21 (4.02%)
FFL 17.88 Decreased By ▼ -0.15 (-0.83%)
FNEL 1.30 No Change ▼ 0.00 (0%)
HUMNL 11.06 Increased By ▲ 0.06 (0.55%)
KEL 8.04 Decreased By ▼ -0.07 (-0.86%)
KOSM 5.45 Increased By ▲ 0.07 (1.3%)
MLCF 87.11 Decreased By ▼ -0.94 (-1.07%)
NBP 184.60 Decreased By ▼ -1.88 (-1.01%)
PACE 11.62 Increased By ▲ 0.90 (8.4%)
PAEL 40.30 Increased By ▲ 0.36 (0.9%)
PIAHCLA 26.17 No Change ▼ 0.00 (0%)
PIBTL 17.10 Decreased By ▼ -0.22 (-1.27%)
PPL 228.48 Decreased By ▼ -4.30 (-1.85%)
PRL 34.55 Decreased By ▼ -0.40 (-1.14%)
PTC 67.43 Decreased By ▼ -0.13 (-0.19%)
SEARL 91.00 Increased By ▲ 0.07 (0.08%)
SSGC 26.88 Decreased By ▼ -0.29 (-1.07%)
TELE 8.53 Decreased By ▼ -0.04 (-0.47%)
THCCL 66.14 Increased By ▲ 6.01 (10%)
TPLP 9.33 Increased By ▲ 0.57 (6.51%)
TREET 24.56 Increased By ▲ 0.02 (0.08%)
TRG 71.50 Decreased By ▼ -0.25 (-0.35%)
WAVES 10.98 Increased By ▲ 1.00 (10.02%)
WTL 1.27 Increased By ▲ 0.01 (0.79%)
By

UK’s FTSE 100 edged higher at open on Tuesday, led by mining and healthcare stocks, while shares of Ocado jumped after the online supermarket group kept its full-year guidance unchanged.

By 0716 GMT, the blue-chip FTSE 100 added 0.1%, while the more domestically-focussed FTSE 250 midcap index rose 0.2%.

Miners of both industrial and precious metals rose 0.5% each, as most metal prices appreciated on a softer dollar.

Ocado jumped 7.3% after the online supermarket and technology group kept its financial guidance for the year as it reported a return to underlying profit in its first half.

UK’s FTSE 100 falls as weak China data hits commodity stocks

AstraZeneca rose 0.8% after the US Food and Drug Administration (FDA) said it had approved the drugmaker and partner Sanofi’s antibody therapy to prevent respiratory syncytial virus (RSV) in infants and toddlers.

Darktrace jumped 20.1% after the cyber-security company said a review by auditing firm EY showed “a number of areas” where its systems, processes or controls could be improved, but added that the report will not impact its previous financial statements.

Comments

Comments are closed for this article.